Guangdong Marubi Biotechnology Co., Ltd.

SSE:603983.SS

46.27 (CNY) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 846.6491,017.436600.043685.839655.665683.79477.034582.66476.746588.019326.522434.501382.674649.317263.915469.68404.116607.696343.573423.364370.356589.267396.733450.066364.791520.106327.124393.49335.044
Cost of Revenue 202.741285.691152.909176.335167.95206.177131.453167.188149.325181.037114.614124.237127.402216.291112.743168.172145.831219.49112.707129.823127.727185.116131.021134.732122.588163.28108.257114.499112.926
Gross Profit 643.908731.745447.135509.504487.715477.613345.58415.471327.421406.982211.908310.264255.273433.026151.171301.508258.286388.206230.866293.541242.629404.151265.712315.334242.204356.826218.868278.991222.118
Gross Profit Ratio 0.7610.7190.7450.7430.7440.6980.7240.7130.6870.6920.6490.7140.6670.6670.5730.6420.6390.6390.6720.6930.6550.6860.670.7010.6640.6860.6690.7090.663
Reseach & Development Expenses 15.92719.10818.59119.59216.25518.0615.23115.6413.35715.62112.66211.4513.19312.14113.74112.89311.71414.92711.45913.8059.96316.9919.859.2878.7418.9057.9928.6288.297
General & Administrative Expenses 24.534-28.64652.087-1.65220.81-30.88559.381-6.93220.746-36.60961.675-7.24224.71-29.28352.15-4.18121.138-20.88924.106-4.76414.845-17.5625.921-0.88215.253-23.84616.30522.86112.735
Selling & Marketing Expenses 441.717447.267405.289384.842332.646403.108281.903310.886202.708311.477174.266216.934143.48257.8168.169197.556117.77188.355134.962153.55287.23174.761127.593163.22374.873165.101150.479140.5178.5
SG&A 466.251418.621457.375405.555357.276436.745341.283303.954223.454274.868235.941209.691168.191228.518220.319193.375138.908167.465159.068148.789102.075157.201153.514162.34290.126141.255166.784163.37191.236
Other Expenses -4.254195.218-86.322-3.35-2.243-5.0070.071-0.0253.71759.377-33.93939.9943.930.343-5.47615.836-0.069-0.1790.133-0.002-5.111-0.0191.926-0.382-0.153-0.0141.1120.9910.039
Operating Expenses 477.924632.947389.644428.497375.774459.812326.186356.357240.529349.866214.665261.135185.314306.663213.474218.54155.055234.984165.033155.698112.041223.05163.377165.995103.533165.018178.715174.113104.221
Operating Income 165.98498.79857.49181.007111.94217.80127.54167.00396.63959.46110.14258.48379.252140.059-52.16695.19115.908158.67187.978176.705149.171185.367119.044165.669142.569206.09244.601116.878116.6
Operating Income Ratio 0.1960.0970.0960.1180.1710.0260.0580.1150.2030.1010.0310.1350.2070.216-0.1980.2030.2870.2610.2560.4170.4030.3150.30.3680.3910.3960.1360.2970.348
Total Other Income Expenses Net 0.168-0.3020.0113.9620.014-1.8750.071-0.025-0.421-0.134-0.522-0.1010.0020.343-0.43810.798-0.069-0.1790.133-0.002-5.111-0.0191.926-0.382-0.153-0.0141.1120.9910.039
Income Before Tax 166.15198.49657.594.97129.69127.70727.61266.97996.21859.3279.6258.38179.253140.402-52.604105.988115.839158.49288.11176.703144.06185.348120.97165.286142.416206.07845.713117.869116.639
Income Before Tax Ratio 0.1960.0970.0960.1380.1980.1870.0580.1150.2020.1010.0290.1340.2070.216-0.1990.2260.2870.2610.2560.4170.3890.3150.3050.3670.390.3960.140.30.348
Income Tax Expense 30.954-4.079-5.2628.56619.06623.205-15.55214.50117.3436.9818.2168.85615.09735.953-3.67619.18516.97133.0218.31527.41925.21529.55518.65130.54322.45227.2437.34918.98420.681
Net Income 135.045102.82562.26665.908110.62985.5943.14452.01578.6754.1731.40451.59365.476105.918-47.14689.021100.128126.43569.836149.284118.845155.794102.747136.137120.211179.43840.99798.88595.958
Net Income Ratio 0.160.1010.1040.0960.1690.1250.090.0890.1650.0920.0040.1190.1710.163-0.1790.190.2480.2080.2030.3530.3210.2640.2590.3020.330.3450.1250.2510.286
EPS 0.340.2560.160.160.280.210.110.130.20.140.0040.130.160.26-0.120.220.250.310.170.380.30.390.260.370.330.960.220.280.27
EPS Diluted 0.340.2560.160.160.280.210.110.130.20.140.0030.130.160.26-0.120.220.250.310.170.380.30.390.260.370.330.960.220.280.27
EBITDA 167.018104.13468.119101.701131.21134.61129.96875.871104.63468.63519.55469.43389.545150.833-52.858113.056123.111164.40388.587182.23130.588191.566102.335169.031148.673207.96340.153116.611119.873
EBITDA Ratio 0.1970.1020.1140.1480.20.1970.0630.130.2190.1170.060.160.2340.232-0.20.2410.3050.2710.2580.430.3530.3250.2580.3760.4080.40.1230.2960.358